G Roveroni
Overview
Explore the profile of G Roveroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basso D, Mazza S, Greco E, Belluco C, Roveroni G, Navaglia F, et al.
Anticancer Res
. 2001 Nov;
21(4A):2665-70.
PMID: 11724336
Background: We ascertained in vitro whether there were any differences in the growth of fibroblasts and the production of collagen (PIIIP), in relation to the presence of conditioning sera or...
2.
Piva M, Navaglia F, Basso D, Fogar P, Roveroni G, Gallo N, et al.
Oncology
. 2000 Nov;
59(4):323-8.
PMID: 11096345
Objective: It has been suggested that the molecular identification of cancer cells in the circulation may be useful in predicting the presence of micrometastasis in several cancer types. The aim...
3.
Herszenyi L, Plebani M, Carraro P, De Paoli M, Roveroni G, Cardin R, et al.
Clin Chim Acta
. 2000 Feb;
291(2):171-87.
PMID: 10675722
Cysteine and serine proteases are involved in cancer invasion and metastasis. In the past few years we investigated the tissue levels of these proteases in gastric cancer (GC), gastric precancerous...
4.
Herszenyi L, Plebani M, Carraro P, De Paoli M, Roveroni G, Cardin R, et al.
Cancer
. 1999 Oct;
86(7):1135-42.
PMID: 10506696
Background: Cathepsin B (CATB) and cathepsin L (CATL), which are cysteine proteases, urokinase-(UPA) and tissue-type plasminogen activator (TPA), both serine proteases, and their inhibitor type-1 (PAI-1) are believed to play...
5.
Basso D, Navaglia F, Brigato L, Piva M, Toma A, Greco E, et al.
Gut
. 1999 Apr;
43(2):182-6.
PMID: 10189841
Background: Helicobacter pylori species comprise different strains, cytotoxic and non-cytotoxic, which can be identified on the basis of their genomic pattern. Aims: (1) To evaluate the polymorphism of the vacA...
6.
Plebani M, Herszenyi L, Carraro P, De Paoli M, Roveroni G, Cardin R, et al.
Clin Exp Metastasis
. 1997 Jul;
15(4):418-25.
PMID: 9219730
The urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 are thought to play an important part in gastric cancer (GC) invasion and metastasis. Little is known about the behavior and...
7.
Plebani M, Basso D, Roveroni G, De Paoli M, Galeotti F, Corsini A
Cancer
. 1997 Apr;
79(7):1299-303.
PMID: 9083150
Background: The first step of colorectal carcinoma spread depends on the ability of the tumor cells to degrade and invade the extracellular matrix (ECM). The objectives of the current study...
8.
Fogar P, Basso D, Pasquali C, De Paoli M, Sperti C, Roveroni G, et al.
Anticancer Res
. 1997 Mar;
17(2B):1227-30.
PMID: 9137477
Background: The neural adhesion molecule N-CAM, a membrane bound glycoprotein, seems to play an important role in the development of normal tissue architecture and in contact-dependent inhibition of cell growth....
9.
Farinati F, Herszenyi L, Plebani M, Carraro P, De Paoli M, Cardin R, et al.
Carcinogenesis
. 1996 Dec;
17(12):2581-7.
PMID: 9006092
Background: Cysteine proteases [cathepsin B (CATB), cathepsin L (CATL)], the serine protease urokinase-type plasminogen activator (UPA) and its inhibitor type-1 (PAI-1) play an important part in cancer invasion. No data...
10.
Plebani M, De Paoli M, Basso D, Roveroni G, Giacomini A, Galeotti F, et al.
J Surg Oncol
. 1996 Aug;
62(4):239-44.
PMID: 8691835
Early diagnosis of colorectal cancer, a frequent neoplasia in industrialized countries, permits curative surgery. In this study we assessed the clinical role of serum tumor markers determination in diagnosing, staging,...